243 related articles for article (PubMed ID: 17903585)
1. Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma.
Périé S; Hugentobler A; Susini B; Balogova S; Grahek D; Kerrou K; Montravers F; Chater PE; St Guily JL; Talbot JN
Otolaryngol Head Neck Surg; 2007 Oct; 137(4):647-53. PubMed ID: 17903585
[TBL] [Abstract][Full Text] [Related]
2. FDG-PET scan in local follow-up of irradiated head and neck squamous cell carcinomas.
Conessa C; Hervé S; Foehrenbach H; Poncet JL
Ann Otol Rhinol Laryngol; 2004 Aug; 113(8):628-35. PubMed ID: 15330142
[TBL] [Abstract][Full Text] [Related]
3. The impact of FDG-PET/CT on the management of head and neck tumours: the radiotherapist's perspective.
Dietl B; Marienhagen J; Kühnel T; Schreyer A; Kölbl O
Oral Oncol; 2008 May; 44(5):504-8. PubMed ID: 17826307
[TBL] [Abstract][Full Text] [Related]
4. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography.
Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP
Eur J Nucl Med; 1999 Jul; 26(7):767-73. PubMed ID: 10398825
[TBL] [Abstract][Full Text] [Related]
5. Prospective comparison of FDG and FET PET/CT in patients with head and neck squamous cell carcinoma.
Balogova S; Périé S; Kerrou K; Grahek D; Montravers F; Angelard B; Susini B; El Chater P; St Guily JL; Talbot JN
Mol Imaging Biol; 2008; 10(6):364-73. PubMed ID: 18668293
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography (PET) in the management of oro-pharyngeal cancer.
Jones J; Farag I; Hain SF; McGurk M
Eur J Surg Oncol; 2005 Mar; 31(2):170-6. PubMed ID: 15698734
[TBL] [Abstract][Full Text] [Related]
7. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of 18F-FDG PET/CT for diagnosing cervical nodal metastases in patients with oral cavity or oropharynx carcinoma.
Piao Y; Bold B; Tayier A; Ishida R; Omura K; Okada N; Shibuya H
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):933-8. PubMed ID: 19846326
[No Abstract] [Full Text] [Related]
9. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET prediction of head and neck squamous cell cancer outcomes.
Schwartz DL; Rajendran J; Yueh B; Coltrera MD; Leblanc M; Eary J; Krohn K
Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1361-7. PubMed ID: 15611393
[TBL] [Abstract][Full Text] [Related]
11. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.
Yao M; Smith RB; Graham MM; Hoffman HT; Tan H; Funk GF; Graham SM; Chang K; Dornfeld KJ; Menda Y; Buatti JM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):991-9. PubMed ID: 16099601
[TBL] [Abstract][Full Text] [Related]
12. Does 18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up?
Salaun PY; Abgral R; Querellou S; Couturier O; Valette G; Bizais Y; Kraeber-Bodéré F
Head Neck; 2007 Dec; 29(12):1115-20. PubMed ID: 17636537
[TBL] [Abstract][Full Text] [Related]
13. FDG PET in oral and oropharyngeal cancer. Value for confirmation of N0 neck and detection of occult metastases.
Krabbe CA; Dijkstra PU; Pruim J; van der Laan BF; van der Wal JE; Gravendeel JP; Roodenburg JL
Oral Oncol; 2008 Jan; 44(1):31-6. PubMed ID: 17306603
[TBL] [Abstract][Full Text] [Related]
14. Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report.
Yao M; Graham MM; Smith RB; Dornfeld KJ; Skwarchuk M; Hoffman HT; Funk GF; Graham SM; Menda Y; Buatti JM
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1410-8. PubMed ID: 15590172
[TBL] [Abstract][Full Text] [Related]
15. Direct comparison of F-18-FDG PET and ultrasound in the follow-up of patients with squamous cell cancer of the head and neck.
Goerres GW; Haenggeli CA; Allaoua M; Albrecht SR; Dulguerov P; Becker M; Allal AS; Lehmann W; Slosman DO
Nuklearmedizin; 2000 Dec; 39(8):246-50. PubMed ID: 11189902
[TBL] [Abstract][Full Text] [Related]
16. [Impact of FDG-PET in therapeutic management of patients with suspected recurrence of head and neck cancer].
Pasamontes Pingarrón JA; Cabrera Martín MN; Carreras Delgado JL; Scola Yurrita B; Calvo Manuel F; Pérez Castejón MJ
Rev Esp Med Nucl; 2006 Sep; 25(5):294-300. PubMed ID: 17173775
[TBL] [Abstract][Full Text] [Related]
17. (18)F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma.
Kim JW; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Br J Cancer; 2013 Dec; 109(12):2973-9. PubMed ID: 24149172
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
Ng SH; Lin CY; Chan SC; Lin YC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Chang CJ; Wang JJ
PLoS One; 2014; 9(12):e115933. PubMed ID: 25531391
[TBL] [Abstract][Full Text] [Related]
19. FDG-PET in radiotherapy treatment planning of advanced head and neck cancer--a prospective clinical analysis.
Dietl B; Marienhagen J; Kühnel T; Schaefer C; Kölbl O
Auris Nasus Larynx; 2006 Sep; 33(3):303-9. PubMed ID: 16497462
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.
Lonneux M; Hamoir M; Reychler H; Maingon P; Duvillard C; Calais G; Bridji B; Digue L; Toubeau M; Grégoire V
J Clin Oncol; 2010 Mar; 28(7):1190-5. PubMed ID: 20124179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
